Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Atrial FibrillationCardiovascular DiseasesHeart DiseasesArrhythmias, CardiacPathologic Processes
Interventions
DEVICE

Insertable Cardiac Monitor or external non-invasive LT-ECG patch

"Implantable device that provides accurate daily transmission. Patients without an existing CIED who prefer to use noninvasive LT-ECG monitoring will be offered to use the Carnation Ambulatory Monitor (CAM™; Bardy Diagnostics) the CAM™ patch approved for LT-ECG monitoring applied to the skin over the chest for a time-period of 7-days every 2 months for cardiac electrical data for arrhythmia detection."

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Rochester

OTHER